| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 23, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 4 | Conversion of derivative security | 101,918 | -- | 110,503 |
| Feb 18, 2020 |
Chief Administrative Officer
Trans History: 6
|
Chief Administrative Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | -- | 100,000 |
| May 04, 2020 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 80,923 | -- | 80,923 |
| May 04, 2020 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 80,923 | -- | 80,923 |
| Jun 13, 2023 |
Director
Trans History: 9
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 65,789 | $0.76 | 65,789 |
| Oct 01, 2018 |
Chief Commercial Officer
Trans History: 5
|
Chief Commercial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 64,640 | -- | 64,640 |
| May 13, 2022 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 60,000 | $0.56 | 121,579 |
| May 13, 2022 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 60,000 | -- | 117,500 |
| Mar 01, 2019 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
| Mar 01, 2019 |
Chief Commercial Officer
Trans History: 5
|
Chief Commercial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- | 60,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.